S'abonner

Genome-wide association study reveals class I MHC–restricted T cell–associated molecule gene (CRTAM) variants interact with vitamin D levels to affect asthma exacerbations - 03/02/12

Doi : 10.1016/j.jaci.2011.09.034 
Rose Du, MD, PhD a, b, c, , Augusto A. Litonjua, MD a, c, d, Kelan G. Tantisira, MD a, c, d, Jessica Lasky-Su, ScD a, c, Shamil R. Sunyaev, PhD c, Barbara J. Klanderman, PhD a, c, Juan C. Celedón, MD, DrPH a, e, Lydiana Avila, MD f, Manuel E. Soto-Quiros, MD, PhD f, Scott T. Weiss, MD a, c, d
a Channing Laboratory, Brigham and Women’s Hospital, Boston, Mass 
b Department of Neurosurgery, Brigham and Women’s Hospital, Boston, Mass 
d Center for Genomic Medicine, Brigham and Women’s Hospital, Boston, Mass 
c Harvard Medical School, Boston, Mass 
e Division of Pediatric Pulmonary Medicine, Allergy and Immunology, Department of Pediatrics, Children’s Hospital of UPMC, University of Pittsburgh School of Medicine, Pittsburgh, Pa 
f Division of Pediatric Pulmonology, Hospital Nacional de Niños, San José, Costa Rica 

Corresponding author: Rose Du, MD, PhD, Department of Neurosurgery, Brigham and Women’s Hospital, 75 Francis St, Boston, MA 02115.

Abstract

Background

It has recently been shown that vitamin D deficiency can increase asthma development and severity and that variations in vitamin D receptor genes are associated with asthma susceptibility.

Objective

We sought to find genetic factors that might interact with vitamin D levels to affect the risk of asthma exacerbation.

Methods

We conducted a genome-wide study of gene–vitamin D interaction on asthma exacerbations using population-based and family-based approaches on 403 subjects and trios from the Childhood Asthma Management Program. Twenty-three polymorphisms with significant interactions were studied in a replication analysis in 584 children from a Costa Rican cohort.

Results

We identified 3 common variants in the class I MHC–restricted T cell–associated molecule gene (CRTAM) that were associated with an increased rate of asthma exacerbations based on the presence of a low circulating vitamin D level. These results were replicated in a second independent population (unadjusted combined interaction, P = .00028-.00097; combined odds ratio, 3.28-5.38). One variant, rs2272094, is a nonsynonymous coding polymorphism of CRTAM. Functional studies on cell lines confirmed the interaction of vitamin D and rs2272094 on CRTAM expression. CRTAM is highly expressed in activated human CD8+ and natural killer T cells, both of which have been implicated in asthmatic patients.

Conclusion

The findings highlight an important gene-environment interaction that elucidates the role of vitamin D and CD8+ and natural killer T cells in asthma exacerbation in a genome-wide gene-environment interaction study that has been replicated in an independent population. The results suggest the potential importance of maintaining adequate vitamin D levels in subsets of high-risk asthmatic patients.

Le texte complet de cet article est disponible en PDF.

Key words : Gene-environment interaction, genome-wide association study, vitamin D, asthma exacerbation

Abbreviations used : CAMP, CRTAM, OR, PLCL1, SNP, TTS


Plan


 Supported by National Institutes of Health (NIH) grants R21HL089842 and R01HL092197. We acknowledge the Childhood Asthma Management Program (CAMP) investigators and research team, supported by the National Heart, Lung, and Blood Institute (NHLBI), for collection of CAMP Genetic Ancillary Study data. All work on data collected from the CAMP Genetic Ancillary Study was conducted at the Channing Laboratory of the Brigham and Women’s Hospital under appropriate CAMP policies and human subjects’ protections. The CAMP Genetics Ancillary Study is supported by U01 HL075419, U01 HL65899, P01 HL083069, R01 HL086601, and T32 HL07427 from the NHLBI/NIH.
 Disclosure of potential conflict of interest: A. A. Litonjua, K. G. Tantisira, S. R. Sunyaev, B. J. Klanderman, and M. E. Soto-Quiros receive research support from the National Institutes of Health. J. C. Celedón is on the advisory board for Genentech, receives research support from the NIH, and receives royalties from UpToDate. The rest of the authors declare that they have no relevant conflicts of interest.


© 2011  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 129 - N° 2

P. 368 - février 2012 Retour au numéro
Article précédent Article précédent
  • The effect of single and multiple infections on atopy and wheezing in children
  • Neuza Maria Alcantara-Neves, Rafael Valente Veiga, Vitor Camilo Cavalcante Dattoli, Rosimeire Leovigildo Fiaccone, Renata Esquivel, Álvaro Augusto Cruz, Philip John Cooper, Laura Cunha Rodrigues, Maurício Lima Barreto
| Article suivant Article suivant
  • Interaction between filaggrin null mutations and tobacco smoking in relation to asthma
  • Nikolaj Drimer Berg, Lise Lotte N. Husemoen, Betina Heinsbæk Thuesen, Lars-Georg Hersoug, Jesper Elberling, Jacob Pontoppidan Thyssen, Berit Christina Carlsen, Jeanne Duus Johansen, Torkil Menné, Klaus Bønnelykke, Steen Stender, Michael Meldgaard, Pal Bela Szecsi, Allan Linneberg

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.